Connection

Sui-Yuan Chang to Treatment Outcome

This is a "connection" page, showing publications Sui-Yuan Chang has written about Treatment Outcome.
Connection Strength

0.022
  1. Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics. J Formos Med Assoc. 2021 May; 120(5):1269-1273.
    View in: PubMed
    Score: 0.008
  2. Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients. Int J Antimicrob Agents. 2019 Jul; 54(1):35-42.
    View in: PubMed
    Score: 0.007
  3. Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection. PLoS One. 2016; 11(12):e0169228.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.